Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Kühberger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Trends in Genetics : TIG|February 15, 2023
Bridging biological cfDNA features and machine learning approachesTina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Molecular Oncology|January 22, 2025
Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patientsMatthias Unseld, Stefan Kühberger, Ricarda Graf, et al.
British Journal of Cancer|January 9, 2026
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibilityGeorgios Vlachos, Tina Moser, Isaac Lazzeri, et al.
Journal of Translational Medicine|January 30, 2023
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell linesChristina Karner, Ines Anders, Djenana Vejzovic, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Trends in Genetics : TIG|February 15, 2023
Bridging biological cfDNA features and machine learning approachesTina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Molecular Oncology|January 22, 2025
Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patientsMatthias Unseld, Stefan Kühberger, Ricarda Graf, et al.
British Journal of Cancer|January 9, 2026
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibilityGeorgios Vlachos, Tina Moser, Isaac Lazzeri, et al.
Journal of Translational Medicine|January 30, 2023
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell linesChristina Karner, Ines Anders, Djenana Vejzovic, et al.
Pageof 1